Accumulating evidence gathered from multiple populations supports the effect of polymorphisms in non-HLA genes, such as PTPN22, FCRL3 (25) and vitamin D receptor gene (26), on modulating beta-cell function in T1D subjects. The gene discussed is VDR; the disease is type 1 diabetes mellitus.